Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
企業コードSTXS
会社名Stereotaxis Inc
上場日Aug 12, 2004
最高経営責任者「CEO」Mr. David Leo Fischel
従業員数139
証券種類Ordinary Share
決算期末Aug 12
本社所在地710 N Tucker Blvd
都市ST. LOUIS
証券取引所NYSE American Consolidated
国United States of America
郵便番号63101
電話番号13146786100
ウェブサイトhttps://www.stereotaxis.com/
企業コードSTXS
上場日Aug 12, 2004
最高経営責任者「CEO」Mr. David Leo Fischel
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし